Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pan-European SMART Study
NCT00463866Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
Phase 4, randomised, open-label trial of budesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Number of Severe Asthma Exacerbations Per Participant at 6 months. Started Mar 2007; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00463866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463866.